Compounds > atenolol

atenolol and halothane

atenolol has been researched along with halothane in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Abraham, MH; Acree, WE; Ibrahim, A1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Day, MD; Hemsworth, BA; Roach, AG; Street, JA1
Harron, DW; Shanks, RG; Uprichard, AG; Wilson, R1
Bruandet, N; Quintin, L; Rentero, N; Viale, JP1

Other Studies

7 other study(ies) available for atenolol and halothane

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats.
    Archives internationales de pharmacodynamie et de therapie, 1979, Volume: 237, Issue:2

    Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Atenolol; Catalysis; Halothane; Injections, Intravenous; Male; Nitrous Oxide; Oxidation-Reduction; Rats; Tissue Distribution

1979
Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
    British journal of pharmacology, 1988, Volume: 95, Issue:4

    Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Arrhythmias, Cardiac; Atenolol; Coronary Vessels; Dogs; Drug Therapy, Combination; Electrophysiology; Epinephrine; Female; Halothane; Hemodynamics; Ligation; Male; Ouabain; Tetrahydroisoquinolines

1988
Catechol activation in the vasomotor center upon emergence from anesthesia: specificity.
    Synapse (New York, N.Y.), 1998, Volume: 30, Issue:2

    Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Atenolol; Catecholamines; Decerebrate State; Electrochemistry; Epinephrine; Halothane; Male; Morphine; Narcotics; Nitroprusside; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasodilator Agents; Vasomotor System

1998